Buprenorphine Sublingual
Buprenorphine Sublingual is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Buprenorphine Sublingual. Available dosage form: tablet.
Drug details
- Generic Name
- Buprenorphine Sublingual
- Brand Names
- Buprenorphine Sublingual
- Application Number
- ANDA201760
- Sponsor
- Direct_Rx
- NDC Codes
- 1
- Dosage Forms
- TABLET
- Routes
- SUBLINGUAL
- Active Ingredients
- BUPRENORPHINE HYDROCHLORIDE
Indications and Usage
Buprenorphine sublingual tablet is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablet should be used as part of a complete treatment plan to include counseling and psychosocial support.